Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial.
Cheng-Fong ChenChih-Chien HuChen-Te WuHung-Ta H WuChun-Shin ChangYi-Pei HungChia-Chu TsaiYuhan ChangPublished in: Stem cell research & therapy (2021)
ClinicalTrials.gov Identifier: NCT02784964. Registered 16 May, 2016-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02784964.
Keyphrases
- knee osteoarthritis
- clinical trial
- double blind
- open label
- phase ii
- phase iii
- stem cell transplantation
- computed tomography
- placebo controlled
- bone marrow
- contrast enhanced
- image quality
- magnetic resonance imaging
- randomized controlled trial
- study protocol
- positron emission tomography
- wound healing
- low dose
- magnetic resonance
- high dose
- pet ct